Dennis D. Kim - May 17, 2021 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Chief Medical Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Dennis D. Kim
Stock symbol
CBAY
Transactions as of
May 17, 2021
Transactions value $
$0
Form type
4
Date filed
5/17/2021, 06:57 PM
Next filing
Jan 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +390K $0.00 390K May 17, 2021 Common Stock 390K $4.37 Direct F1
transaction CBAY Employee Stock Option (right to buy) Award $0 +10K $0.00 10K May 17, 2021 Common Stock 10K $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.